Adma Biologics | ADMA - Equity Capital And Reserves


Adma Biologics reported $477.32M in Equity Capital and Reserves for its fiscal quarter ending in December of 2025.





Equity Capital And Reserves Change Date
Adma Biologics USD 477.32M 46.13M Dec/2025
Alnylam Pharmaceuticals USD 789.18M 555.28M Dec/2025
BioCryst Pharmaceuticals USD -119.15M 268.74M Dec/2025
Minerva Neurosciences USD -140.75M 106.17M Dec/2025
Novavax USD -127.75M 28.92M Dec/2025
Omeros USD -228.68M 15.13M Jun/2025
Takeda JPY 7.64T 513.39B Dec/2025